+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
Central Retinal Vein Occlusion - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Central Retinal Vein Occlusion - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 121 Pages
  • Global
From
Refractory Multiple Myeloma - Pipeline Insight, 2024 - Product Thumbnail Image

Refractory Multiple Myeloma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Postpartum Depression Market Report 2025 - Product Thumbnail Image

Postpartum Depression Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
Post-Traumatic Stress Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Post-Traumatic Stress Disorder Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Retinal Drugs Market 2024-2028 - Product Thumbnail Image

Retinal Drugs Market 2024-2028

  • Report
  • July 2024
  • 180 Pages
  • Global
From
From
Pulmonary Embolism Market Report 2025 - Product Thumbnail Image

Pulmonary Embolism Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Non-cancerous Skin Diseases Therapeutics Market 2025-2029 - Product Thumbnail Image

Non-cancerous Skin Diseases Therapeutics Market 2025-2029

  • Report
  • February 2025
  • 222 Pages
  • Global
From
Loading Indicator